Table 4 Clinician-assessed outcomes

ROM (°)

Control (ref.)

77.6

Gout

59.7

−17.9

−26.8

−8.9

<0.001

Asymptomatic hyperuricaemia

76.8

−0.8

−9.3

7.7

0.853

Plantarflexion force (N)

Control (ref.)

92.0

Gout

71.3

−20.7

−36.9

−4.6

0.012

Asymptomatic hyperuricaemia

114.8

22.8

7.5

38.1

0.004

Dorsiflexion force (N)

Control (ref.)

57.3

Gout

58.0

0.8

−10.7

12.2

0.896

Asymptomatic hyperuricaemia

65.4

8.1

−2.7

19.0

0.139

Foot Posture Index

Control (ref.)

+4.8

Gout

+6.2

1.3

−0.4

3.1

0.134

Asymptomatic hyperuricaemia

+6.6

1.8

0.1

3.4

0.036

Plantar temperature (°C)

Control (ref.)

24.3

Gout

26.2

1.9

0.6

3.1

0.004

Asymptomatic hyperuricaemia

25.1

0.8

−0.5

2.0

0.218

Dorsal temperature (°C)

Control (ref.)

25.8

Gout

27.7

1.9

0.6

3.1

0.003

Asymptomatic hyperuricaemia

26.5

0.6

−0.6

1.9

0.295

Medial temperature (°C)

Control (ref.)

25.2

Gout

27.0

1.8

0.6

3.1

0.004

Asymptomatic hyperuricaemia

25.9

0.8

−0.4

2.0

0.219

p

Lower

Upper

Hallux Valgus Severity^a

Control (ref.)

Gout

0.284

0.085

0.947

0.041

Asymptomatic hyperuricaemia

0.968

0.968

0.296

0.957